Sub-section menu :

Content :

Communication / Conference: WHO issues draft guidance to test suspected spurious, falsely-labelled, falsified and counterfeit medicines

November 1st, 2016 - OMS


The World Health Organisation (WHO) issued in October 2016 a draft guidance to test suspected spurious/falsely-labelled/falsified/counterfeit (SFFC) medicines. It expects the industry to comment before January 10, 2017. This document provides technical guidance on laboratory testing of samples of suspected SFFC products detected on the market of WHO Member States and related aspects of sampling and reporting.

 

ASOP EU

Fight the fakes

IRACM